Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia
- DOI
- 10.25405/ncl.34656564.v1
- Published
- 2026
- Container
- Not recorded
- Publisher
- Newcastle University
- Open access
- no
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- supportingPublication license: A publication license was supplied: https://rightsstatements.org/page/InC/1.0/?language=en. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.25405/ncl.34656564.v1,
title = {Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia},
author = {CN Harrison and PJ Campbell and G Buck and K Wheatley and CL East and D Bareford and BS Wilkins and JD van der Walt and JT Reilly and AP Grigg and P Revell and BE Woodcock and AR Green and TC Pearson},
year = {2026},
doi = {10.25405/ncl.34656564.v1},
url = {https://doi.org/10.25405/ncl.34656564.v1}
}RIS
TY - JOUR TI - Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia AU - CN Harrison AU - PJ Campbell AU - G Buck AU - K Wheatley AU - CL East AU - D Bareford AU - BS Wilkins AU - JD van der Walt AU - JT Reilly AU - AP Grigg AU - P Revell AU - BE Woodcock AU - AR Green AU - TC Pearson PY - 2026 DO - 10.25405/ncl.34656564.v1 UR - https://doi.org/10.25405/ncl.34656564.v1 ER -
APA
Harrison, C., Campbell, P., Buck, G., Wheatley, K., East, C., Bareford, D., Wilkins, B., Walt, J. V. D., Reilly, J., Grigg, A., Revell, P., Woodcock, B., Green, A., & Pearson, T. (2026). Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia. https://doi.org/10.25405/ncl.34656564.v1
Source records
- datacite · retrieved 2026-11-10T12:38:00.069Z